Dopamine Agents: all 740 studies that test it
Page 6 of 8. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.
- Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine AbuseCompletedNCT01967381Early Phase 1
- Targeting Dopamine Therapy in RLSStatus unknownNCT01937169Not applicable
- The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's DiseaseCompletedNCT01921972Phase 4
- Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's DiseaseStatus unknownNCT01849042Phase 4
- Memantine Monotherapy for Executive Dysfunction and ADHDWithdrawnNCT01844427Not applicable
- Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF EpisodesCompletedNCT01777555Phase 2
- Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Multiple SclerosisCompletedNCT01744444Phase 2
- Renal Function During Laparoscopic SurgeryCompletedNCT01722630Not applicable
- Mechanisms of Neuromuscular Fatigue Post StrokeCompletedNCT01688570Early Phase 1
- Remission of ICD by Switching Dopamine Agonist to Levodopa/CarbidopaCompletedNCT01683253Phase 4
- Randomised Controlled Trial of Memantine in FibromyalgiaStatus unknownNCT01653457Phase 3
- Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive DisorderTerminatedNCT01650740Not applicable
- Antipsychotic Augmentation With L-DopaCompletedNCT01636037Phase 2
- Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber ChangedWithdrawnNCT01619566Phase 4
- Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" EpisodesCompletedNCT01617135Phase 2
- Study in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food EffectsCompletedNCT01607034Phase 1
- Study of NMDA Antagonists and Neuropathic PainCompletedNCT01602185Phase 2
- Dexpramipexole and Warfarin Drug Drug Interaction (DDI) StudyCompletedNCT01597310Phase 1
- Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's DiseaseCompletedNCT01538329Phase 2
- Dexpramipexole and Cimetidine Drug Drug Interaction (DDI)CompletedNCT01536249Phase 1
- Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)CompletedNCT01511029Phase 1
- Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's DiseaseCompletedNCT01504178Phase 3
- A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's DiseaseCompletedNCT01484990Phase 1
- Management of Hypotension In the Preterm InfantTerminatedNCT01482559Phase 3
- Multiparametric MRI Study of Endogenous Analgesia and Prediction the Efficacy of Migraine Pharmacological PreventionCompletedNCT01470352Not applicable
- Improvement the Anti-migraine Treatment Efficacy by Tailoring the Drug to Individual's Pain Modulation ProfileCompletedNCT01470339Not applicable
- Urinary Excretion of Acetylamantadine by Normal Healthy VolunteersCompletedNCT01467258Not applicable
- Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy VolunteersCompletedNCT01461174Phase 1
- A Trial of Memantine as Symptomatic Treatment for Early Huntington DiseaseCompletedNCT01458470Phase 2
- Dexpramipexole SAD/MAD StudyCompletedNCT01449578Phase 1
- Effect of Duloxetine and Venlafaxine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol: A Three-phase Randomized Balanced Cross-over Study in Healthy VolunteersCompletedNCT01443520Phase 4
- Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes SubjectsCompletedNCT01441986Phase 2
- Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)CompletedNCT01437293Phase 1
- Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation TherapyTerminatedNCT01430351Phase 1
- Dopamine Versus Dobutamine for Treatment of Arterial Hypotension in Term and Preterm NeonatesStatus unknownNCT01427686Phase 4
- Duloxetine for Pain in Older Adults With Knee Osteoarthritis (OA)CompletedNCT01425827Not applicable
- Dexpramipexole Renal PK StudyCompletedNCT01424176Phase 1
- Predicting Medication Response in Obsessive Compulsive DisorderCompletedNCT01404871Not applicable
- Treatment Resistant Geriatric Depression in Primary CareCompletedNCT01392287Phase 1
- Inflammatory Markers and Cognitive Function in Major DepressionStatus unknownNCT01391221Phase 4
- A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)CompletedNCT01372449Phase 2
- Pretreatment Identification of Duloxetine Success in Neuropathic Pain PatientsCompletedNCT01363284Not applicable
- Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled StudyStatus unknownNCT01361373Phase 4
- Mechanism-based Choice of Therapy for Neuropathic PainCompletedNCT01359514Not applicable
- Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy VolunteersCompletedNCT01327261Phase 4
- Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With FibromyalgiaCompletedNCT01323374Phase 2
- Effect of Intravenous Amantadine on Gait Freezing in Parkinson's DiseaseCompletedNCT01313845Phase 4
- Comparing Different Levodopa/Carbidopa/Entacapone Treatment RegimensCompletedNCT01296464Phase 2
- Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus ErythematosusCompletedNCT01269866Not applicable
- Mechanism-based Choice of Therapy: Can Treatments Success in Fibromyalgia Patients be Coupled to Psychophysical Pain Modulation Profile?Status unknownNCT01268631Not applicable
- Investigation of Memantine in the Treatment of Memory, Concentration or Attention ProblemsCompletedNCT01261741Phase 2
- Dopaminergic Modulation of Cognition and Psychomotor FunctionCompletedNCT01218425Not applicable
- A Study of the Effect of Memantine on Pharmacokinetics, Safety and Tolerability of Single Dose RO5313534 in Healthy Volunteers, and the Effect of RO5313534 on Safety and Tolerability of Steady State MemantineCompletedNCT01196065Phase 1
- Pilot Study of Maintenance Therapy With Intravenous AMANTADINEStatus unknownNCT01190553Not applicable
- Psychopharmacotherapy in Multiple Substances AbuseCompletedNCT01189214Phase 3
- Series Studies of Bipolar Disorder-Valproate add-on MemantineCompletedNCT01188148Phase 2/3
- Comparison of the Efficacy of Duloxetine With Placebo in Patients With Chronic Low Back Pain With a Radicular ComponentCompletedNCT01166048Phase 4
- Study to Assess Mechanisms in Peripheral Tissue Innervation for FibromyalgiaCompletedNCT01127490Not applicable
- Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or PregabalinWithdrawnNCT01116531Phase 4
- Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's DiseaseCompletedNCT01108029Phase 4
- Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)Status unknownNCT01099059Phase 2
- Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced DyskinesiaCompletedNCT01092065Phase 2
- A Study for Adolescents With Fibromyalgia SyndromeWithdrawnNCT01089621Phase 4
- Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk GenotypeStatus unknownNCT01078870Phase 4
- Study on Cognitive Disorders of Multiple SclerosisCompletedNCT01074619Phase 3
- Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) StudyCompletedNCT01044992Not applicable
- Memantine for Post-Operative Pain ControlStatus unknownNCT01041313Phase 4
- A Study to Assess the Effect of Safinamide on Levodopa PharmacokineticsCompletedNCT01026428Phase 1/2
- Exelon Patch and Combination With Memantine Comparative TrialCompletedNCT01025466Phase 4
- Memantine Therapy in Amyotrophic Lateral SclerosisCompletedNCT01020331Phase 2
- Amantadine as Adjunctive Therapy to Antipsychotics in SchizophreniaStatus unknownNCT00999505Phase 3
- Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)CompletedNCT00990067Phase 1
- The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?WithdrawnNCT00988663Not applicable
- Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With EpilepsyWithdrawnNCT00986115Not applicable
- The Influence of Glutamate on Memory in HumansCompletedNCT00980408Not applicable
- Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised SubjectsCompletedNCT00979251Phase 2
- Amantadine for Improving Neurologic Symptoms in Ataxia-TelangiectasiaCompletedNCT00950196Phase 4
- Effect of Dopaminergic Medication on Recovery of AphasiaCompletedNCT00941265Not applicable
- Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)CompletedNCT00940693Phase 2
- Dopamine in Acute Decompensated Heart Failure (DAD-HF) TrialStatus unknownNCT00937092Phase 4
- A Study to Evaluate the Pharmacokinetics of Duloxetine in Chinese Han Healthy SubjectsCompletedNCT00933452Phase 1
- Assessment of Cognitive Functioning Before and After Treatment With DuloxetineCompletedNCT00933439Not applicable
- An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease SubjectsCompletedNCT00914602Phase 1/2
- Duodenal Levodopa Infusion, Quality of Life and Autonomic Nervous System in Parkinson's DiseaseCompletedNCT00914134Phase 4
- Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) InhibitorsCompletedNCT00906828Phase 4
- Duloxetine for Major Depression in Peri-/Postmenopausal WomenStatus unknownNCT00889369Phase 4
- Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa PharmacokineticsCompletedNCT00888186Phase 4
- Early Blood Pressure Management in Extremely Premature InfantsCompletedNCT00874393Phase 1
- Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy BodiesCompletedNCT00855686Phase 4
- Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A InfectionTerminatedNCT00830323Phase 2
- Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose EstimationCompletedNCT00829634Not applicable
- Effect of Levodopa on Human Multifocal ElectroretinogramCompletedNCT00812760Phase 4
- Memantine and Validation of a New Alzheimer's Disease ScaleCompletedNCT00804271Phase 3
- Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's DiseaseCompletedNCT00800709Phase 4
- Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI)WithdrawnNCT00800514Not applicable
- Effects of Duloxetine on Fear Conditioning in Posttraumatic Stress Disorder (PTSD)CompletedNCT00763178Early Phase 1
- Memantine as Adjunctive Therapy for Schizophrenia Negative SymptomsCompletedNCT00757978Phase 4
- Memantine on Aggression and Agitation of Alzheimer's Disease (AD)Status unknownNCT00703430Not applicable
- Pharmacokinetic Study With Repeated Doses of StalevoCompletedNCT00693862Phase 1
- Amantadine for Treatment of Symptoms of the Post-traumatic Confusional StateCompletedNCT00693121Phase 4